Peinado M A, Malkhosyan S, Velazquez A, Perucho M
California Institute of Biological Research, La Jolla 92037.
Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10065-9. doi: 10.1073/pnas.89.21.10065.
The arbitrarily primed polymerase chain reaction (AP-PCR) [Welsh, J. & McClelland, M. (1990) Nucleic Acids Res. 18, 7213-7218] has been used to detect somatic genetic alterations in tumors of the colon and rectum. DNA fingerprints generated by single arbitrary primers were compared between normal and tumor tissue of the same individuals. AP-PCR bands showing decreased and increased intensities in tumor tissue DNA, relative to normal, have been cloned after reamplification with the same arbitrary primer. Standard restriction fragment length polymorphism and Southern blot analyses show that these DNA sequences have undergone allelic losses and gains, respectively, in the tumor cell genome. The deleted sequences have been assigned to the short arm of chromosome 17 by PCR of somatic hamster/human cell hybrids and linkage analysis. These results show the ability of the AP-PCR to detect and isolate, in a single step, DNA sequences representing two of the genetic alterations that underlie the aneuploidy of cancer cells: losses of heterozygosity and chromosomal gains. Altogether, they also show the quantitative nature of the amplification levels obtained in vitro by AP-PCR, which thus provides the basis for an alternative molecular approach to cancer cytogenetics.
任意引物聚合酶链反应(AP-PCR)[威尔士,J. & 麦克莱兰,M.(1990年)《核酸研究》18卷,7213 - 7218页]已被用于检测结肠和直肠肿瘤中的体细胞遗传改变。在同一个体的正常组织和肿瘤组织之间比较了由单个任意引物产生的DNA指纹图谱。相对于正常组织,在肿瘤组织DNA中显示强度降低和增加的AP-PCR条带,在用相同的任意引物重新扩增后进行了克隆。标准的限制性片段长度多态性和Southern印迹分析表明,这些DNA序列在肿瘤细胞基因组中分别经历了等位基因的缺失和增加。通过体细胞仓鼠/人类细胞杂交体的PCR和连锁分析,已将缺失的序列定位到17号染色体的短臂上。这些结果表明,AP-PCR能够在一步中检测和分离代表癌细胞非整倍体基础的两种遗传改变的DNA序列:杂合性缺失和染色体增加。总之,它们还显示了通过AP-PCR在体外获得的扩增水平的定量性质,因此为癌症细胞遗传学提供了一种替代分子方法的基础。